Skip to main content
. Author manuscript; available in PMC: 2020 Oct 9.
Published in final edited form as: Am J Cardiol. 2016 Apr 6;117(12):1921–1927. doi: 10.1016/j.amjcard.2016.03.040

Table 2.

Adjusted Hazard Ratio (95% Confidence Limits) for the Likelihood of Coronary Heart Disease and Cardiovascular Events by Study Groups

Hazard ratio (95% confidence interval) per standard deviation
Variable MetS (without DM) (N= 1596) DM (N= 838) Neither DM nor MetS (N=3983)
CHD Events 139 105 218
Model 1: HDL Discordance 0.84 (0.68–1.04) 0.88 (0.72–1.08) 0.94 (0.80–1.10)
§ Model 2: LDL Discordance 1.21 (1.01–1.47)* 0.88 (0.71–1.10) 0.87 (0.74–1.02)
|| Model 3:
 HDL-C 1.12 (0.73–1.73) 1.00 (0.70–1.43) 1.14 (0.90–1.45)
 HDL-P 0.86 (0.63–1.17) 0.71 (0.52–0.96)* 0.82 (0.66–1.03)
 LDL-C 0.80 (0.59–1.08) 1.47 (1.07–2.03)* 1.27 (1.01–1.59)*
 LDL-P 1.34 (1.01–1.78)* 0.82 (0.58–1.17) 0.93 (0.71–1.22)
CVD Events 200 152 307
Model 1: HDL Discordance 0.95 (0.80–1.13) 0.90 (0.77–1.06) 0.88 (0.77–1.01)
§ Model 2: LDL Discordance 1.26 (1.07–1.47) 0.88 (0.74–1.06) 0.91 (0.79–1.04)
|| Model 3:
 HDL-C 1.05 (0.74–1.48) 0.98 (0.73–1.32) 1.12 (0.92–1.37)
 HDL-P 0.97 (0.76–1.25) 0.75 (0.58–0.97)* 0.80 (0.66–0.96)*
 LDL-C 0.77 (0.60–1.00) 1.41 (1.08–1.84)* 1.17 (0.96–1.42)
 LDL-P 1.39 (1.09–1.75) 0.76 (0.57–1.02) 0.99 (0.79–1.24)
*

p < 0.05,

p<0.01

All models were adjustments for age, sex, race/ethnicity, family history, systolic blood pressure, use of blood pressure medication, smoking, body mass index, statin use.

Model 1 additionally adjusted for LDL-C and LDL-P.

§

Model 2 additionally adjusted for HDL-C and HDL-P

||

Model 3 include simultaneous adjustment with all four lipid variables